NBD AI Bulletin -- Huadong Medicine Co., Ltd (SZ 000963, close price: 37.2 yuan) released on August 9 the semi-annual results, saying that in the first half of 2021, the Company posted revenue of about 17.179 billion yuan, up 3.11% year on year, the net profit attributable to shareholder amounted to about 1.3 billion yuan, a decrease of 24.89% from a year earlier, and the basic earnings per share was 0.7431 yuan, a decrease of 24.89% compared with the same period last year.

The 2020 annual report shows that the main business of Huadong Medicine Co Ltd is the commercial brokerage and agency industry, pharmaceutical manufacturing, international aesthetic medicine business, inter-division offset, accounting for 68.32%, 33.84%, 0.95%, -3.1% of revenue, respectively.

Huadong Medicine's chairman is Lyu Liang, male, 47 years old, master's degree. Huadong Medicine's general manager is Li Yuedong, male, 49, master's degree.

(By Gao Han)

Disclaimer: The content and data of this article are for reference only and do not constitute investment advice. Please verify before use. Any action you take upon the information on this website is at your own risk.